Innovation Drives Operational Challenges that Impact R&D Productivity

innovation

by Elizabeth Iorns, Ph.D., CEO and Co-Founder, Science Exchange Originally appeared in the 2017 Fierce Life Science Innovation Report (download PDF) R&D productivity and efficiency are key measures for evaluating the success of biotech and pharma companies. In theory, investing resources into R&D to boost those measures should yield positive results. Unfortunately, recent trends suggest […]

Read More…

Science Exchange Wins Two Gold Stevie® Awards in 2017 Stevie Awards for Women in Business

elizabeth

Dr. Elizabeth Iorns Honored as Female Entrepreneur of the Year and Science Exchange as Most Innovative Company of the Year Palo Alto, CA – November 21, 2017 — Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D), today announced that CEO and Co-Founder Dr. Elizabeth Iorns, has been […]

Read More…

Elizabeth Iorns, Ph.D., CEO of Science Exchange Elected to the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT)

elizabeth

PALO ALTO, CA, November 15, 2017 – Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D) services, announced today that Elizabeth Iorns, Ph.D., CEO of Science Exchange, has been elected to serve her first term on the Board of Directors of the Drug, Chemical & Associated Technologies Association […]

Read More…

Elizabeth Iorns, Ph.D., Named 2017 Scrip Award Executive of the Year Finalist

elizabeth

PALO ALTO CA, November 1, 2017 –  Science Exchange, the world’s leading and most secure platform for outsourced research and development (R&D), announced today that company CEO and co-founder Elizabeth Iorns, Ph.D., has been selected as an Executive of the Year finalist in the prestigious 2017 Scrip Awards. Dr. Iorns is one of six C-level […]

Read More…

Accelerating Innovation and Mitigating Risk in Outsourced R&D

acceleration-innovation

Science Exchange recently hosted a group of procurement executives from multiple industries for our 2017 Science Exchange Outsourced R&D Leadership Summit. During the informative and interactive sessions, we discussed both the challenges and opportunities that organizations are facing as they seek to effectively manage outsourced R&D services. From presentations by procurement leaders from major pharmaceutical […]

Read More…

Science Exchange Honored by Goldman Sachs for Entrepreneurship

Elizabeth Iorns, Ph.D., CEO and Co-Founder of Science Exchange

Co-Founder and CEO Elizabeth Iorns Among 100 Most Intriguing Entrepreneurs at 2017 Builders + Innovators Summit Palo Alto, CA – October 19, 2017 – Goldman Sachs (NYSE:GS) is recognizing Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange as one of the 100 Most Intriguing Entrepreneurs of 2017 at its Builders + Innovators Summit in […]

Read More…

Two Papers Published in the Online Journal PeerJ; First Step to Reproducing Critical Prostate Cancer Findings.

papers

Science Exchange published two papers in PeerJ, the online journal, that are being funded by the Prostate Cancer Foundation-Movember Foundation Reproducibility Initiative. This initiative seeks to address growing concerns about reproducibility in scientific research by conducting replications of recent papers in the field of prostate cancer.  It is a collaboration between the Prostate Cancer Foundation, […]

Read More…

Experience that led to Science Exchange featured in Science magazine

elizabeth

Science magazine recently published a short article by Science Exchange Founder & CEO Elizabeth Iorns outlining a specific experience that changed her career goals. Elizabeth’s article documents her first experience with the systematic bias against reproducibility in the academic research world, which led ultimately to the creation of Science Exchange. The article is copied below: During the first year […]

Read More…